- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
NSF and NIH Recognize Kortemme's Leadership in AI-Driven Protein Design
Wed May 28, 2025

Tanja Kortemme, PhD
Department of Bioengineering and Therapeutic Sciences professor and Vice Dean of Research Tanja Kortemme, PhD, is pushing the boundaries of protein engineering with research that uses artificial intelligence to design shapeshifting proteins — dynamic molecules that mimic the complex movements of natural proteins.
Published in Science, her lab’s latest study reveals an essential characteristic for regulating biological processes such as metabolism and cell signaling, which could enable new classes of therapeutics, biosensors, and environmentally sustainable materials.
Kortemme’s lab continues to attract support for its innovative approach. She recently received a $1.4 million award from the National Science Foundation as part of a $7.2 million collaborative investment across four institutions and a company, focused on using deep learning to engineer programmable, sustainable biosynthesis. The team’s target: a fully recyclable, heat-resistant bioplastic.
Adding to Kortemme’s momentum, her application and interview for the NIH Pioneer Award application — a prestigious and highly competitive grant — placed her proposal among the top 8 percent. While final funding decisions are pending, the recognition reflects strong enthusiasm for her vision of integrating AI and molecular design to advance health and sustainability.
Read the full story on her latest work
More
Tags
Category:
Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.